UAE’s Medcare Treats First International SMA Patient With Revolutionary Intrathecal Gene Therapy

Contributed by: Business Wire

Logo

Business Wire logo

Images

World's first international patient, who received intrathecal gene therapy at Medcare Royal Hospital in Dubai, UAE, along with parents, and the hospital team. (Photo: AETOSWire)
World's first international patient, who received intrathecal gene therapy at Medcare Royal Hospital in Dubai, UAE, along with parents, and the hospital team. (Photo: AETOSWire)
Business Wire embedded0

Tags

Health
Consumer
Genetics
Other Health
Children
Pharmaceutical
Medcare

More Like This

Dr. Vivek Mundada with Medcare multidisciplinary medical team (Photo: AETOSWire)

Dubai’s Medcare Hospital Becomes the World’s First to Treat an Adult Spinal Muscular Atrophy (SMA) Patient Outside the US

PR Newswire associated0

The Department of Health - Abu Dhabi provides gene therapy for Duchenne Muscular Dystrophy for the first time in Abu Dhabi and outside the US

SK pharmteco and GEMMABio Expand Rare Disease Manufacturing Collaboration Following Important Spinal Muscular Atrophy (SMA) Clinical Trial Milestone

Every baby in England to get life-saving genetic test from birth

baby Aiyla,

A heartbreaking race against time: £600,000 needed to save 9-month-old UK baby Aiyla's life, Zolgensma is the only hope against SMA type 1.

UCSF Benioff Children's Hospitals Become the First US Qualified Treatment Center Contracted to Administer Individualized Gene Therapy WASKYRA®

PR Newswire associated0

Abu Dhabi Stem Cells Center Successfully Manufactures UAE's First CAR-T Cell to Treat an 11-Year Old Leukemia Patient

PR Newswire associated0

Department of Health - Abu Dhabi and Opus Genetics Announce Collaboration to Advance Ground-Breaking Gene Therapy Research for Inherited Retinal Diseases